Nicholas Malden

66 year

Electronic Technology

Profile

Nicholas Malden is Chief Financial Officer, Secretary & Senior Vice President of Ventana Medical Systems, Inc. He joined Ventana in October 2000 and resigned as Senior Vice President, Chief Financial Officer, and Corporate Secretary during 2007.
From 1985 until joining Ventana, Mr. Malden was Vice President-Finance for the Duracell Global Business Management Group at Duracell International.
Mr. Malden received a BA in Political Science from the Grinnell College and an MBA from the Emory University.

Former positions of Nicholas Malden

Companies	Position	End
Ventana Medical Systems, Inc. Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ.	Director of Finance/CFO	2007-04-30

See the detail of Nicholas Malden's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nicholas Malden's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Ventana Medical Systems, Inc. Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ.	Electronic Technology